Articles
Media
Publications
Conferences
CME/CE
Resources
Subscribe

Spotlight -

ZEISS Clinical Cases|

Heidelberg Engineering: Enhancing the Patient Journey

Nitish Mehta, MD

Articles by Nitish Mehta, MD

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema

ByMartin David Harp,Hattie Hayes,Nitish Mehta, MD

May 6th 2025

Latest Updated Articles

© 2025 MJH Life Sciences^®

All rights reserved.